nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—epilepsy syndrome	0.487	1	CbGaD
Risedronate—Histamine Phosphate—HRH3—epilepsy syndrome	0.00293	0.488	CrCbGaD
Risedronate—Histamine Phosphate—CA4—epilepsy syndrome	0.00246	0.41	CrCbGaD
Risedronate—FDPS—forebrain—epilepsy syndrome	0.00167	0.111	CbGeAlD
Risedronate—FDPS—telencephalon—epilepsy syndrome	0.00153	0.102	CbGeAlD
Risedronate—FDPS—medulla oblongata—epilepsy syndrome	0.00121	0.0802	CbGeAlD
Risedronate—FDPS—midbrain—epilepsy syndrome	0.0011	0.0733	CbGeAlD
Risedronate—FDPS—spinal cord—epilepsy syndrome	0.00107	0.0715	CbGeAlD
Risedronate—FDPS—head—epilepsy syndrome	0.000955	0.0636	CbGeAlD
Risedronate—FDPS—nervous system—epilepsy syndrome	0.000906	0.0603	CbGeAlD
Risedronate—FDPS—central nervous system—epilepsy syndrome	0.000872	0.058	CbGeAlD
Risedronate—FDPS—cerebellum—epilepsy syndrome	0.000852	0.0567	CbGeAlD
Risedronate—FDPS—brain—epilepsy syndrome	0.000692	0.0461	CbGeAlD
Risedronate—PTGS2—forebrain—epilepsy syndrome	0.000639	0.0425	CbGeAlD
Risedronate—Histamine Phosphate—CYP2D6—epilepsy syndrome	0.000611	0.102	CrCbGaD
Risedronate—PTGS2—telencephalon—epilepsy syndrome	0.000588	0.0391	CbGeAlD
Risedronate—PTGS2—medulla oblongata—epilepsy syndrome	0.000462	0.0307	CbGeAlD
Risedronate—PTGS2—midbrain—epilepsy syndrome	0.000422	0.0281	CbGeAlD
Risedronate—PTGS2—spinal cord—epilepsy syndrome	0.000412	0.0274	CbGeAlD
Risedronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—FOS—epilepsy syndrome	0.000385	0.00912	CbGpPWpGaD
Risedronate—PTGS2—S1P1 pathway—KDR—epilepsy syndrome	0.000382	0.00905	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CA13—epilepsy syndrome	0.000373	0.00885	CbGpPWpGaD
Risedronate—PTGS2—head—epilepsy syndrome	0.000366	0.0244	CbGeAlD
Risedronate—PTGS2—Arachidonic acid metabolism—CYP2C19—epilepsy syndrome	0.000351	0.00833	CbGpPWpGaD
Risedronate—PTGS2—nervous system—epilepsy syndrome	0.000347	0.0231	CbGeAlD
Risedronate—PTGS2—central nervous system—epilepsy syndrome	0.000334	0.0222	CbGeAlD
Risedronate—PTGS2—cerebellum—epilepsy syndrome	0.000327	0.0217	CbGeAlD
Risedronate—PTGS2—Selenium Micronutrient Network—TXNRD1—epilepsy syndrome	0.00032	0.0076	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—CASP6—epilepsy syndrome	0.000306	0.00726	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.000301	0.00713	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MBP—epilepsy syndrome	0.000294	0.00696	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CERS1—epilepsy syndrome	0.000283	0.00671	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GLUD1—epilepsy syndrome	0.000283	0.00671	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ADK—epilepsy syndrome	0.000283	0.00671	CbGpPWpGaD
Risedronate—FDPS—Metabolism—FAR1—epilepsy syndrome	0.000283	0.00671	CbGpPWpGaD
Risedronate—FDPS—Metabolism—L2HGDH—epilepsy syndrome	0.000283	0.00671	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PDXK—epilepsy syndrome	0.000283	0.00671	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—epilepsy syndrome	0.000283	0.00671	CbGpPWpGaD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—MEF2C—epilepsy syndrome	0.000283	0.0067	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—SLIT2—epilepsy syndrome	0.000281	0.00667	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—BCL2—epilepsy syndrome	0.000281	0.00666	CbGpPWpGaD
Risedronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—epilepsy syndrome	0.000276	0.00655	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MIF—epilepsy syndrome	0.000271	0.00642	CbGpPWpGaD
Risedronate—PTGS2—brain—epilepsy syndrome	0.000265	0.0177	CbGeAlD
Risedronate—PTGS2—Spinal Cord Injury—GDNF—epilepsy syndrome	0.000262	0.0062	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PNPO—epilepsy syndrome	0.000259	0.00614	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NHLRC1—epilepsy syndrome	0.000259	0.00614	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GAMT—epilepsy syndrome	0.000259	0.00614	CbGpPWpGaD
Risedronate—FDPS—Metabolism—EPM2A—epilepsy syndrome	0.000259	0.00614	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—AQP1—epilepsy syndrome	0.000246	0.00583	CbGpPWpGaD
Risedronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—epilepsy syndrome	0.000241	0.00572	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CA4—epilepsy syndrome	0.000241	0.0057	CbGpPWpGaD
Risedronate—FDPS—Metabolism—QDPR—epilepsy syndrome	0.000241	0.0057	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—PDYN—epilepsy syndrome	0.000239	0.00567	CbGpPWpGaD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—FOS—epilepsy syndrome	0.000239	0.00567	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—NTF3—epilepsy syndrome	0.000235	0.00557	CbGpPWpGaD
Risedronate—FDPS—Metabolism—COX3—epilepsy syndrome	0.000226	0.00536	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—GFAP—epilepsy syndrome	0.000225	0.00533	CbGpPWpGaD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—epilepsy syndrome	0.000223	0.00528	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—AQP4—epilepsy syndrome	0.000222	0.00527	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CAPN1—epilepsy syndrome	0.000221	0.00524	CbGpPWpGaD
Risedronate—FDPS—Metabolism—KCNB1—epilepsy syndrome	0.000214	0.00508	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CACNA2D2—epilepsy syndrome	0.000214	0.00508	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PFKL—epilepsy syndrome	0.000214	0.00508	CbGpPWpGaD
Risedronate—FDPS—Metabolism—SLCO1A2—epilepsy syndrome	0.000214	0.00508	CbGpPWpGaD
Risedronate—FDPS—Metabolism—SLC6A8—epilepsy syndrome	0.000214	0.00508	CbGpPWpGaD
Risedronate—PTGS2—S1P1 pathway—VEGFA—epilepsy syndrome	0.00021	0.00499	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	0.00021	0.00497	CbGpPWpGaD
Risedronate—PTGS2—Arachidonic acid metabolism—GPX1—epilepsy syndrome	0.000209	0.00496	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	0.000208	0.00494	CbGpPWpGaD
Risedronate—FDPS—SREBP signalling—AKT1—epilepsy syndrome	0.0002	0.00473	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NEU1—epilepsy syndrome	0.000196	0.00465	CbGpPWpGaD
Risedronate—FDPS—Metabolism—UPB1—epilepsy syndrome	0.000196	0.00465	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ATIC—epilepsy syndrome	0.000196	0.00465	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—PLAT—epilepsy syndrome	0.00019	0.00451	CbGpPWpGaD
Risedronate—FDPS—Metabolism—HSD17B4—epilepsy syndrome	0.000189	0.00448	CbGpPWpGaD
Risedronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—epilepsy syndrome	0.000183	0.00434	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GBE1—epilepsy syndrome	0.000182	0.00432	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPP1R3C—epilepsy syndrome	0.000182	0.00432	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—TNF—epilepsy syndrome	0.00018	0.00427	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	0.000178	0.00423	CbGpPWpGaD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—epilepsy syndrome	0.000172	0.00407	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ASAH1—epilepsy syndrome	0.000171	0.00406	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CXCL2—epilepsy syndrome	0.000171	0.00404	CbGpPWpGaD
Risedronate—FDPS—Metabolism—STXBP1—epilepsy syndrome	0.000167	0.00395	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NT5E—epilepsy syndrome	0.000163	0.00385	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALAD—epilepsy syndrome	0.000163	0.00385	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALDH7A1—epilepsy syndrome	0.000155	0.00368	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CACNA1A—epilepsy syndrome	0.000155	0.00368	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOS—epilepsy syndrome	0.000155	0.00367	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CCR2—epilepsy syndrome	0.000154	0.00366	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	0.000152	0.00361	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	0.000152	0.00361	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ST3GAL3—epilepsy syndrome	0.000152	0.0036	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ADSL—epilepsy syndrome	0.000149	0.00352	CbGpPWpGaD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—epilepsy syndrome	0.000148	0.0035	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—CAT—epilepsy syndrome	0.000147	0.00349	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GLUL—epilepsy syndrome	0.000146	0.00346	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—HES1—epilepsy syndrome	0.000145	0.00344	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CACNA1D—epilepsy syndrome	0.000143	0.00339	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	0.000142	0.00337	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	0.000142	0.00337	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—NOS1—epilepsy syndrome	0.000141	0.00335	CbGpPWpGaD
Risedronate—Pruritus—Zonisamide—epilepsy syndrome	0.000139	0.000308	CcSEcCtD
Risedronate—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000138	0.000307	CcSEcCtD
Risedronate—Flatulence—Gabapentin—epilepsy syndrome	0.000138	0.000306	CcSEcCtD
Risedronate—Urticaria—Lamotrigine—epilepsy syndrome	0.000138	0.000306	CcSEcCtD
Risedronate—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000138	0.000306	CcSEcCtD
Risedronate—Nausea—Propofol—epilepsy syndrome	0.000137	0.000305	CcSEcCtD
Risedronate—Vomiting—Fosphenytoin—epilepsy syndrome	0.000137	0.000305	CcSEcCtD
Risedronate—Diarrhoea—Felbamate—epilepsy syndrome	0.000137	0.000305	CcSEcCtD
Risedronate—Vertigo—Pregabalin—epilepsy syndrome	0.000137	0.000304	CcSEcCtD
Risedronate—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000137	0.000304	CcSEcCtD
Risedronate—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000137	0.000304	CcSEcCtD
Risedronate—Dizziness—Diazepam—epilepsy syndrome	0.000137	0.000304	CcSEcCtD
Risedronate—Infection—Valproic Acid—epilepsy syndrome	0.000137	0.000304	CcSEcCtD
Risedronate—Syncope—Pregabalin—epilepsy syndrome	0.000137	0.000304	CcSEcCtD
Risedronate—Rash—Fosphenytoin—epilepsy syndrome	0.000136	0.000302	CcSEcCtD
Risedronate—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000136	0.000302	CcSEcCtD
Risedronate—Haemoglobin—Topiramate—epilepsy syndrome	0.000136	0.000302	CcSEcCtD
Risedronate—Asthenia—Clonazepam—epilepsy syndrome	0.000136	0.000301	CcSEcCtD
Risedronate—Rhinitis—Topiramate—epilepsy syndrome	0.000135	0.000301	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—RELA—epilepsy syndrome	0.000135	0.00321	CbGpPWpGaD
Risedronate—Back pain—Gabapentin—epilepsy syndrome	0.000135	0.0003	CcSEcCtD
Risedronate—Headache—Fosphenytoin—epilepsy syndrome	0.000135	0.0003	CcSEcCtD
Risedronate—Haemorrhage—Topiramate—epilepsy syndrome	0.000135	0.0003	CcSEcCtD
Risedronate—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000135	0.0003	CcSEcCtD
Risedronate—Asthenia—Phenytoin—epilepsy syndrome	0.000135	0.000299	CcSEcCtD
Risedronate—Nausea—Midazolam—epilepsy syndrome	0.000134	0.000299	CcSEcCtD
Risedronate—Muscle spasms—Gabapentin—epilepsy syndrome	0.000134	0.000299	CcSEcCtD
Risedronate—Diarrhoea—Zonisamide—epilepsy syndrome	0.000134	0.000298	CcSEcCtD
Risedronate—Pharyngitis—Topiramate—epilepsy syndrome	0.000134	0.000298	CcSEcCtD
Risedronate—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000134	0.000298	CcSEcCtD
Risedronate—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000134	0.000298	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—APEX1—epilepsy syndrome	0.000134	0.00318	CbGpPWpGaD
Risedronate—FDPS—Metabolism—TXNRD1—epilepsy syndrome	0.000134	0.00317	CbGpPWpGaD
Risedronate—Pruritus—Clonazepam—epilepsy syndrome	0.000134	0.000297	CcSEcCtD
Risedronate—Vomiting—Vigabatrin—epilepsy syndrome	0.000134	0.000297	CcSEcCtD
Risedronate—Skin disorder—Valproic Acid—epilepsy syndrome	0.000134	0.000297	CcSEcCtD
Risedronate—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000133	0.000296	CcSEcCtD
Risedronate—Oedema peripheral—Topiramate—epilepsy syndrome	0.000133	0.000296	CcSEcCtD
Risedronate—Cough—Pregabalin—epilepsy syndrome	0.000133	0.000296	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—GPX1—epilepsy syndrome	0.000133	0.00315	CbGpPWpGaD
Risedronate—Pruritus—Phenytoin—epilepsy syndrome	0.000133	0.000295	CcSEcCtD
Risedronate—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000133	0.000295	CcSEcCtD
Risedronate—Nausea—Levetiracetam—epilepsy syndrome	0.000133	0.000295	CcSEcCtD
Risedronate—Rash—Vigabatrin—epilepsy syndrome	0.000133	0.000295	CcSEcCtD
Risedronate—Dizziness—Felbamate—epilepsy syndrome	0.000133	0.000294	CcSEcCtD
Risedronate—Dermatitis—Vigabatrin—epilepsy syndrome	0.000132	0.000294	CcSEcCtD
Risedronate—Urethral disorder—Topiramate—epilepsy syndrome	0.000132	0.000294	CcSEcCtD
Risedronate—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000132	0.000294	CcSEcCtD
Risedronate—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000132	0.000293	CcSEcCtD
Risedronate—Headache—Vigabatrin—epilepsy syndrome	0.000132	0.000293	CcSEcCtD
Risedronate—Hypertension—Pregabalin—epilepsy syndrome	0.000132	0.000292	CcSEcCtD
Risedronate—Vomiting—Diazepam—epilepsy syndrome	0.000132	0.000292	CcSEcCtD
Risedronate—Rash—Diazepam—epilepsy syndrome	0.000131	0.00029	CcSEcCtD
Risedronate—Dermatitis—Diazepam—epilepsy syndrome	0.00013	0.00029	CcSEcCtD
Risedronate—FDPS—Metabolism—AQP1—epilepsy syndrome	0.00013	0.00308	CbGpPWpGaD
Risedronate—Chest pain—Pregabalin—epilepsy syndrome	0.00013	0.000288	CcSEcCtD
Risedronate—Myalgia—Pregabalin—epilepsy syndrome	0.00013	0.000288	CcSEcCtD
Risedronate—Arthralgia—Pregabalin—epilepsy syndrome	0.00013	0.000288	CcSEcCtD
Risedronate—Dizziness—Zonisamide—epilepsy syndrome	0.00013	0.000288	CcSEcCtD
Risedronate—Headache—Diazepam—epilepsy syndrome	0.00013	0.000288	CcSEcCtD
Risedronate—Anxiety—Pregabalin—epilepsy syndrome	0.000129	0.000287	CcSEcCtD
Risedronate—Diarrhoea—Clonazepam—epilepsy syndrome	0.000129	0.000287	CcSEcCtD
Risedronate—Anaemia—Gabapentin—epilepsy syndrome	0.000129	0.000287	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000129	0.000286	CcSEcCtD
Risedronate—Asthenia—Carbamazepine—epilepsy syndrome	0.000129	0.000286	CcSEcCtD
Risedronate—Diarrhoea—Phenytoin—epilepsy syndrome	0.000128	0.000285	CcSEcCtD
Risedronate—Nausea—Fosphenytoin—epilepsy syndrome	0.000128	0.000285	CcSEcCtD
Risedronate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000128	0.000284	CcSEcCtD
Risedronate—Angioedema—Gabapentin—epilepsy syndrome	0.000128	0.000284	CcSEcCtD
Risedronate—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000128	0.000284	CcSEcCtD
Risedronate—Vomiting—Felbamate—epilepsy syndrome	0.000127	0.000283	CcSEcCtD
Risedronate—Dry mouth—Pregabalin—epilepsy syndrome	0.000127	0.000282	CcSEcCtD
Risedronate—Pruritus—Carbamazepine—epilepsy syndrome	0.000127	0.000282	CcSEcCtD
Risedronate—Rash—Felbamate—epilepsy syndrome	0.000126	0.000281	CcSEcCtD
Risedronate—Eye disorder—Topiramate—epilepsy syndrome	0.000126	0.000281	CcSEcCtD
Risedronate—Dermatitis—Felbamate—epilepsy syndrome	0.000126	0.00028	CcSEcCtD
Risedronate—Tinnitus—Topiramate—epilepsy syndrome	0.000126	0.00028	CcSEcCtD
Risedronate—Vertigo—Gabapentin—epilepsy syndrome	0.000126	0.000279	CcSEcCtD
Risedronate—Headache—Felbamate—epilepsy syndrome	0.000126	0.000279	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000125	0.000279	CcSEcCtD
Risedronate—Cardiac disorder—Topiramate—epilepsy syndrome	0.000125	0.000279	CcSEcCtD
Risedronate—Syncope—Gabapentin—epilepsy syndrome	0.000125	0.000279	CcSEcCtD
Risedronate—Dizziness—Clonazepam—epilepsy syndrome	0.000125	0.000278	CcSEcCtD
Risedronate—Nausea—Vigabatrin—epilepsy syndrome	0.000125	0.000278	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	0.000125	0.00296	CbGpPWpGaD
Risedronate—Vomiting—Zonisamide—epilepsy syndrome	0.000125	0.000277	CcSEcCtD
Risedronate—Insomnia—Valproic Acid—epilepsy syndrome	0.000125	0.000277	CcSEcCtD
Risedronate—Asthenia—Lamotrigine—epilepsy syndrome	0.000124	0.000276	CcSEcCtD
Risedronate—Dizziness—Phenytoin—epilepsy syndrome	0.000124	0.000276	CcSEcCtD
Risedronate—Rash—Zonisamide—epilepsy syndrome	0.000124	0.000275	CcSEcCtD
Risedronate—Infection—Pregabalin—epilepsy syndrome	0.000124	0.000275	CcSEcCtD
Risedronate—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000124	0.000275	CcSEcCtD
Risedronate—Dermatitis—Zonisamide—epilepsy syndrome	0.000124	0.000275	CcSEcCtD
Risedronate—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000124	0.000274	CcSEcCtD
Risedronate—Nausea—Diazepam—epilepsy syndrome	0.000123	0.000273	CcSEcCtD
Risedronate—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000123	0.000273	CcSEcCtD
Risedronate—Headache—Zonisamide—epilepsy syndrome	0.000123	0.000273	CcSEcCtD
Risedronate—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000123	0.000273	CcSEcCtD
Risedronate—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000123	0.000272	CcSEcCtD
Risedronate—Angiopathy—Topiramate—epilepsy syndrome	0.000123	0.000272	CcSEcCtD
Risedronate—Pruritus—Lamotrigine—epilepsy syndrome	0.000123	0.000272	CcSEcCtD
Risedronate—Shock—Pregabalin—epilepsy syndrome	0.000122	0.000272	CcSEcCtD
Risedronate—Immune system disorder—Topiramate—epilepsy syndrome	0.000122	0.000271	CcSEcCtD
Risedronate—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000122	0.000271	CcSEcCtD
Risedronate—Cough—Gabapentin—epilepsy syndrome	0.000122	0.000271	CcSEcCtD
Risedronate—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000122	0.000271	CcSEcCtD
Risedronate—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000121	0.000269	CcSEcCtD
Risedronate—Skin disorder—Pregabalin—epilepsy syndrome	0.000121	0.000269	CcSEcCtD
Risedronate—Hypertension—Gabapentin—epilepsy syndrome	0.000121	0.000268	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—CDC42—epilepsy syndrome	0.000121	0.00286	CbGpPWpGaD
Risedronate—Vomiting—Clonazepam—epilepsy syndrome	0.00012	0.000267	CcSEcCtD
Risedronate—Vomiting—Phenytoin—epilepsy syndrome	0.000119	0.000265	CcSEcCtD
Risedronate—Rash—Clonazepam—epilepsy syndrome	0.000119	0.000265	CcSEcCtD
Risedronate—Dermatitis—Clonazepam—epilepsy syndrome	0.000119	0.000265	CcSEcCtD
Risedronate—Arthralgia—Gabapentin—epilepsy syndrome	0.000119	0.000264	CcSEcCtD
Risedronate—Chest pain—Gabapentin—epilepsy syndrome	0.000119	0.000264	CcSEcCtD
Risedronate—Myalgia—Gabapentin—epilepsy syndrome	0.000119	0.000264	CcSEcCtD
Risedronate—Nausea—Felbamate—epilepsy syndrome	0.000119	0.000264	CcSEcCtD
Risedronate—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000119	0.000264	CcSEcCtD
Risedronate—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000119	0.000264	CcSEcCtD
Risedronate—Fatigue—Valproic Acid—epilepsy syndrome	0.000119	0.000264	CcSEcCtD
Risedronate—Anxiety—Gabapentin—epilepsy syndrome	0.000119	0.000264	CcSEcCtD
Risedronate—Dizziness—Carbamazepine—epilepsy syndrome	0.000119	0.000263	CcSEcCtD
Risedronate—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000119	0.000263	CcSEcCtD
Risedronate—Headache—Clonazepam—epilepsy syndrome	0.000118	0.000263	CcSEcCtD
Risedronate—Rash—Phenytoin—epilepsy syndrome	0.000118	0.000263	CcSEcCtD
Risedronate—Mental disorder—Topiramate—epilepsy syndrome	0.000118	0.000263	CcSEcCtD
Risedronate—Dermatitis—Phenytoin—epilepsy syndrome	0.000118	0.000263	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000118	0.000263	CcSEcCtD
Risedronate—Rash—Oxcarbazepine—epilepsy syndrome	0.000118	0.000262	CcSEcCtD
Risedronate—Pain—Valproic Acid—epilepsy syndrome	0.000118	0.000262	CcSEcCtD
Risedronate—Constipation—Valproic Acid—epilepsy syndrome	0.000118	0.000262	CcSEcCtD
Risedronate—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000118	0.000261	CcSEcCtD
Risedronate—Headache—Phenytoin—epilepsy syndrome	0.000118	0.000261	CcSEcCtD
Risedronate—Malnutrition—Topiramate—epilepsy syndrome	0.000118	0.000261	CcSEcCtD
Risedronate—FDPS—Metabolism—KCNJ11—epilepsy syndrome	0.000118	0.00279	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CHRM3—epilepsy syndrome	0.000118	0.00279	CbGpPWpGaD
Risedronate—Headache—Oxcarbazepine—epilepsy syndrome	0.000117	0.00026	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—CRP—epilepsy syndrome	0.000117	0.00277	CbGpPWpGaD
Risedronate—Nausea—Zonisamide—epilepsy syndrome	0.000117	0.000259	CcSEcCtD
Risedronate—Dry mouth—Gabapentin—epilepsy syndrome	0.000116	0.000259	CcSEcCtD
Risedronate—Flatulence—Topiramate—epilepsy syndrome	0.000116	0.000258	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.000115	0.00273	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—BDNF—epilepsy syndrome	0.000115	0.00273	CbGpPWpGaD
Risedronate—Dizziness—Lamotrigine—epilepsy syndrome	0.000115	0.000255	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—epilepsy syndrome	0.000114	0.00271	CbGpPWpGaD
Risedronate—Vomiting—Carbamazepine—epilepsy syndrome	0.000114	0.000253	CcSEcCtD
Risedronate—Back pain—Topiramate—epilepsy syndrome	0.000114	0.000253	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000113	0.000252	CcSEcCtD
Risedronate—Infection—Gabapentin—epilepsy syndrome	0.000113	0.000252	CcSEcCtD
Risedronate—Muscle spasms—Topiramate—epilepsy syndrome	0.000113	0.000251	CcSEcCtD
Risedronate—Rash—Carbamazepine—epilepsy syndrome	0.000113	0.000251	CcSEcCtD
Risedronate—Dermatitis—Carbamazepine—epilepsy syndrome	0.000113	0.000251	CcSEcCtD
Risedronate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000113	0.00025	CcSEcCtD
Risedronate—Insomnia—Pregabalin—epilepsy syndrome	0.000113	0.00025	CcSEcCtD
Risedronate—Nausea—Clonazepam—epilepsy syndrome	0.000112	0.000249	CcSEcCtD
Risedronate—Headache—Carbamazepine—epilepsy syndrome	0.000112	0.000249	CcSEcCtD
Risedronate—Shock—Gabapentin—epilepsy syndrome	0.000112	0.000249	CcSEcCtD
Risedronate—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000112	0.000249	CcSEcCtD
Risedronate—Paraesthesia—Pregabalin—epilepsy syndrome	0.000112	0.000248	CcSEcCtD
Risedronate—Nausea—Phenytoin—epilepsy syndrome	0.000112	0.000248	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—epilepsy syndrome	0.000111	0.00263	CbGpPWpGaD
Risedronate—Dyspnoea—Pregabalin—epilepsy syndrome	0.000111	0.000246	CcSEcCtD
Risedronate—Nausea—Oxcarbazepine—epilepsy syndrome	0.000111	0.000246	CcSEcCtD
Risedronate—Skin disorder—Gabapentin—epilepsy syndrome	0.000111	0.000246	CcSEcCtD
Risedronate—Vomiting—Lamotrigine—epilepsy syndrome	0.00011	0.000245	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	0.000109	0.00259	CbGpPWpGaD
Risedronate—Urticaria—Valproic Acid—epilepsy syndrome	0.000109	0.000243	CcSEcCtD
Risedronate—Rash—Lamotrigine—epilepsy syndrome	0.000109	0.000243	CcSEcCtD
Risedronate—Dermatitis—Lamotrigine—epilepsy syndrome	0.000109	0.000242	CcSEcCtD
Risedronate—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000109	0.000242	CcSEcCtD
Risedronate—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000109	0.000242	CcSEcCtD
Risedronate—Anaemia—Topiramate—epilepsy syndrome	0.000109	0.000242	CcSEcCtD
Risedronate—Headache—Lamotrigine—epilepsy syndrome	0.000109	0.000241	CcSEcCtD
Risedronate—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000107	0.000239	CcSEcCtD
Risedronate—Fatigue—Pregabalin—epilepsy syndrome	0.000107	0.000238	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	0.000107	0.00254	CbGpPWpGaD
Risedronate—Nausea—Carbamazepine—epilepsy syndrome	0.000106	0.000237	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—SRC—epilepsy syndrome	0.000106	0.00252	CbGpPWpGaD
Risedronate—Pain—Pregabalin—epilepsy syndrome	0.000106	0.000236	CcSEcCtD
Risedronate—Constipation—Pregabalin—epilepsy syndrome	0.000106	0.000236	CcSEcCtD
Risedronate—Vertigo—Topiramate—epilepsy syndrome	0.000106	0.000235	CcSEcCtD
Risedronate—Syncope—Topiramate—epilepsy syndrome	0.000106	0.000234	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	0.000105	0.0025	CbGpPWpGaD
Risedronate—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000104	0.000231	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—epilepsy syndrome	0.000104	0.00246	CbGpPWpGaD
Risedronate—Loss of consciousness—Topiramate—epilepsy syndrome	0.000103	0.00023	CcSEcCtD
Risedronate—Insomnia—Gabapentin—epilepsy syndrome	0.000103	0.000229	CcSEcCtD
Risedronate—Nausea—Lamotrigine—epilepsy syndrome	0.000103	0.000229	CcSEcCtD
Risedronate—Cough—Topiramate—epilepsy syndrome	0.000103	0.000228	CcSEcCtD
Risedronate—Paraesthesia—Gabapentin—epilepsy syndrome	0.000102	0.000228	CcSEcCtD
Risedronate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000102	0.000226	CcSEcCtD
Risedronate—Dyspnoea—Gabapentin—epilepsy syndrome	0.000102	0.000226	CcSEcCtD
Risedronate—Hypertension—Topiramate—epilepsy syndrome	0.000102	0.000226	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	0.000102	0.00241	CbGpPWpGaD
Risedronate—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000101	0.000225	CcSEcCtD
Risedronate—Dyspepsia—Gabapentin—epilepsy syndrome	0.0001	0.000223	CcSEcCtD
Risedronate—Arthralgia—Topiramate—epilepsy syndrome	0.0001	0.000223	CcSEcCtD
Risedronate—Myalgia—Topiramate—epilepsy syndrome	0.0001	0.000223	CcSEcCtD
Risedronate—Chest pain—Topiramate—epilepsy syndrome	0.0001	0.000223	CcSEcCtD
Risedronate—Anxiety—Topiramate—epilepsy syndrome	9.98e-05	0.000222	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	9.95e-05	0.000221	CcSEcCtD
Risedronate—Urticaria—Pregabalin—epilepsy syndrome	9.89e-05	0.00022	CcSEcCtD
Risedronate—Asthenia—Valproic Acid—epilepsy syndrome	9.88e-05	0.000219	CcSEcCtD
Risedronate—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	9.85e-05	0.000219	CcSEcCtD
Risedronate—Fatigue—Gabapentin—epilepsy syndrome	9.84e-05	0.000219	CcSEcCtD
Risedronate—Abdominal pain—Pregabalin—epilepsy syndrome	9.84e-05	0.000219	CcSEcCtD
Risedronate—Body temperature increased—Pregabalin—epilepsy syndrome	9.84e-05	0.000219	CcSEcCtD
Risedronate—Dry mouth—Topiramate—epilepsy syndrome	9.8e-05	0.000218	CcSEcCtD
Risedronate—Pain—Gabapentin—epilepsy syndrome	9.76e-05	0.000217	CcSEcCtD
Risedronate—Constipation—Gabapentin—epilepsy syndrome	9.76e-05	0.000217	CcSEcCtD
Risedronate—Pruritus—Valproic Acid—epilepsy syndrome	9.74e-05	0.000216	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	9.68e-05	0.0023	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—CCL2—epilepsy syndrome	9.61e-05	0.00228	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ABCG2—epilepsy syndrome	9.58e-05	0.00227	CbGpPWpGaD
Risedronate—Infection—Topiramate—epilepsy syndrome	9.54e-05	0.000212	CcSEcCtD
Risedronate—Shock—Topiramate—epilepsy syndrome	9.45e-05	0.00021	CcSEcCtD
Risedronate—Diarrhoea—Valproic Acid—epilepsy syndrome	9.42e-05	0.000209	CcSEcCtD
Risedronate—Nervous system disorder—Topiramate—epilepsy syndrome	9.42e-05	0.000209	CcSEcCtD
Risedronate—FDPS—Metabolism—CYP2C19—epilepsy syndrome	9.34e-05	0.00221	CbGpPWpGaD
Risedronate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	9.33e-05	0.000207	CcSEcCtD
Risedronate—Skin disorder—Topiramate—epilepsy syndrome	9.33e-05	0.000207	CcSEcCtD
Risedronate—FDPS—Metabolism—CYP11A1—epilepsy syndrome	9.28e-05	0.0022	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	9.22e-05	0.00219	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	9.21e-05	0.00218	CbGpPWpGaD
Risedronate—Hypersensitivity—Pregabalin—epilepsy syndrome	9.17e-05	0.000204	CcSEcCtD
Risedronate—Dizziness—Valproic Acid—epilepsy syndrome	9.1e-05	0.000202	CcSEcCtD
Risedronate—Urticaria—Gabapentin—epilepsy syndrome	9.07e-05	0.000201	CcSEcCtD
Risedronate—Abdominal pain—Gabapentin—epilepsy syndrome	9.02e-05	0.0002	CcSEcCtD
Risedronate—Body temperature increased—Gabapentin—epilepsy syndrome	9.02e-05	0.0002	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—ALB—epilepsy syndrome	8.95e-05	0.00212	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CA13—epilepsy syndrome	8.94e-05	0.00212	CbGpPWpGaD
Risedronate—Asthenia—Pregabalin—epilepsy syndrome	8.93e-05	0.000198	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—epilepsy syndrome	8.89e-05	0.00211	CbGpPWpGaD
Risedronate—Pruritus—Pregabalin—epilepsy syndrome	8.81e-05	0.000196	CcSEcCtD
Risedronate—Vomiting—Valproic Acid—epilepsy syndrome	8.75e-05	0.000194	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	8.75e-05	0.000194	CcSEcCtD
Risedronate—Insomnia—Topiramate—epilepsy syndrome	8.68e-05	0.000193	CcSEcCtD
Risedronate—Rash—Valproic Acid—epilepsy syndrome	8.68e-05	0.000193	CcSEcCtD
Risedronate—Dermatitis—Valproic Acid—epilepsy syndrome	8.67e-05	0.000193	CcSEcCtD
Risedronate—Headache—Valproic Acid—epilepsy syndrome	8.62e-05	0.000192	CcSEcCtD
Risedronate—Paraesthesia—Topiramate—epilepsy syndrome	8.62e-05	0.000192	CcSEcCtD
Risedronate—Dyspnoea—Topiramate—epilepsy syndrome	8.56e-05	0.00019	CcSEcCtD
Risedronate—PTGS2—C-MYB transcription factor network—BCL2—epilepsy syndrome	8.56e-05	0.00203	CbGpPWpGaD
Risedronate—Diarrhoea—Pregabalin—epilepsy syndrome	8.52e-05	0.000189	CcSEcCtD
Risedronate—Dyspepsia—Topiramate—epilepsy syndrome	8.45e-05	0.000188	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—NOS2—epilepsy syndrome	8.42e-05	0.002	CbGpPWpGaD
Risedronate—Hypersensitivity—Gabapentin—epilepsy syndrome	8.41e-05	0.000187	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.4e-05	0.00199	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CYP2D6—epilepsy syndrome	8.37e-05	0.00199	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—epilepsy syndrome	8.31e-05	0.00197	CbGpPWpGaD
Risedronate—Gastrointestinal disorder—Topiramate—epilepsy syndrome	8.29e-05	0.000184	CcSEcCtD
Risedronate—Fatigue—Topiramate—epilepsy syndrome	8.28e-05	0.000184	CcSEcCtD
Risedronate—Dizziness—Pregabalin—epilepsy syndrome	8.23e-05	0.000183	CcSEcCtD
Risedronate—Pain—Topiramate—epilepsy syndrome	8.21e-05	0.000182	CcSEcCtD
Risedronate—Constipation—Topiramate—epilepsy syndrome	8.21e-05	0.000182	CcSEcCtD
Risedronate—Asthenia—Gabapentin—epilepsy syndrome	8.19e-05	0.000182	CcSEcCtD
Risedronate—Nausea—Valproic Acid—epilepsy syndrome	8.18e-05	0.000182	CcSEcCtD
Risedronate—PTGS2—Disease—PDXK—epilepsy syndrome	8.09e-05	0.00192	CbGpPWpGaD
Risedronate—Pruritus—Gabapentin—epilepsy syndrome	8.07e-05	0.000179	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—RELA—epilepsy syndrome	8.06e-05	0.00191	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ADRA2A—epilepsy syndrome	7.97e-05	0.00189	CbGpPWpGaD
Risedronate—FDPS—Metabolism—BCHE—epilepsy syndrome	7.94e-05	0.00188	CbGpPWpGaD
Risedronate—Vomiting—Pregabalin—epilepsy syndrome	7.91e-05	0.000176	CcSEcCtD
Risedronate—Gastrointestinal pain—Topiramate—epilepsy syndrome	7.85e-05	0.000174	CcSEcCtD
Risedronate—Rash—Pregabalin—epilepsy syndrome	7.85e-05	0.000174	CcSEcCtD
Risedronate—Dermatitis—Pregabalin—epilepsy syndrome	7.84e-05	0.000174	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	7.83e-05	0.00186	CbGpPWpGaD
Risedronate—Diarrhoea—Gabapentin—epilepsy syndrome	7.81e-05	0.000173	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	7.8e-05	0.00185	CbGpPWpGaD
Risedronate—Headache—Pregabalin—epilepsy syndrome	7.8e-05	0.000173	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—FOS—epilepsy syndrome	7.78e-05	0.00184	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	7.7e-05	0.00183	CbGpPWpGaD
Risedronate—Urticaria—Topiramate—epilepsy syndrome	7.63e-05	0.000169	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—CCL2—epilepsy syndrome	7.6e-05	0.0018	CbGpPWpGaD
Risedronate—Body temperature increased—Topiramate—epilepsy syndrome	7.59e-05	0.000169	CcSEcCtD
Risedronate—Abdominal pain—Topiramate—epilepsy syndrome	7.59e-05	0.000169	CcSEcCtD
Risedronate—FDPS—Metabolism—SLC2A1—epilepsy syndrome	7.57e-05	0.0018	CbGpPWpGaD
Risedronate—Dizziness—Gabapentin—epilepsy syndrome	7.55e-05	0.000168	CcSEcCtD
Risedronate—FDPS—Metabolism—PLCB1—epilepsy syndrome	7.49e-05	0.00178	CbGpPWpGaD
Risedronate—FDPS—Metabolism—TH—epilepsy syndrome	7.46e-05	0.00177	CbGpPWpGaD
Risedronate—PTGS2—Disease—PNPO—epilepsy syndrome	7.4e-05	0.00175	CbGpPWpGaD
Risedronate—PTGS2—Disease—EPM2A—epilepsy syndrome	7.4e-05	0.00175	CbGpPWpGaD
Risedronate—PTGS2—Disease—NHLRC1—epilepsy syndrome	7.4e-05	0.00175	CbGpPWpGaD
Risedronate—Nausea—Pregabalin—epilepsy syndrome	7.39e-05	0.000164	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.35e-05	0.00174	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL1B—epilepsy syndrome	7.29e-05	0.00173	CbGpPWpGaD
Risedronate—Vomiting—Gabapentin—epilepsy syndrome	7.26e-05	0.000161	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	7.2e-05	0.00171	CbGpPWpGaD
Risedronate—Rash—Gabapentin—epilepsy syndrome	7.2e-05	0.00016	CcSEcCtD
Risedronate—Dermatitis—Gabapentin—epilepsy syndrome	7.19e-05	0.00016	CcSEcCtD
Risedronate—Headache—Gabapentin—epilepsy syndrome	7.15e-05	0.000159	CcSEcCtD
Risedronate—Hypersensitivity—Topiramate—epilepsy syndrome	7.07e-05	0.000157	CcSEcCtD
Risedronate—Asthenia—Topiramate—epilepsy syndrome	6.89e-05	0.000153	CcSEcCtD
Risedronate—PTGS2—Disease—SV2A—epilepsy syndrome	6.88e-05	0.00163	CbGpPWpGaD
Risedronate—Pruritus—Topiramate—epilepsy syndrome	6.79e-05	0.000151	CcSEcCtD
Risedronate—Nausea—Gabapentin—epilepsy syndrome	6.78e-05	0.000151	CcSEcCtD
Risedronate—PTGS2—Metabolism—FAR1—epilepsy syndrome	6.78e-05	0.00161	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ADK—epilepsy syndrome	6.78e-05	0.00161	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CERS1—epilepsy syndrome	6.78e-05	0.00161	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—L2HGDH—epilepsy syndrome	6.78e-05	0.00161	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GLUD1—epilepsy syndrome	6.78e-05	0.00161	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PDXK—epilepsy syndrome	6.78e-05	0.00161	CbGpPWpGaD
Risedronate—Diarrhoea—Topiramate—epilepsy syndrome	6.57e-05	0.000146	CcSEcCtD
Risedronate—Dizziness—Topiramate—epilepsy syndrome	6.35e-05	0.000141	CcSEcCtD
Risedronate—FDPS—Metabolism—HMOX1—epilepsy syndrome	6.23e-05	0.00148	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PNPO—epilepsy syndrome	6.2e-05	0.00147	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—EPM2A—epilepsy syndrome	6.2e-05	0.00147	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NHLRC1—epilepsy syndrome	6.2e-05	0.00147	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GAMT—epilepsy syndrome	6.2e-05	0.00147	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CAT—epilepsy syndrome	6.15e-05	0.00146	CbGpPWpGaD
Risedronate—PTGS2—Disease—PFKL—epilepsy syndrome	6.13e-05	0.00145	CbGpPWpGaD
Risedronate—Vomiting—Topiramate—epilepsy syndrome	6.1e-05	0.000136	CcSEcCtD
Risedronate—Rash—Topiramate—epilepsy syndrome	6.05e-05	0.000134	CcSEcCtD
Risedronate—Dermatitis—Topiramate—epilepsy syndrome	6.05e-05	0.000134	CcSEcCtD
Risedronate—Headache—Topiramate—epilepsy syndrome	6.01e-05	0.000134	CcSEcCtD
Risedronate—FDPS—Metabolism—ABCB1—epilepsy syndrome	5.98e-05	0.00142	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	5.92e-05	0.0014	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL1B—epilepsy syndrome	5.76e-05	0.00137	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—QDPR—epilepsy syndrome	5.76e-05	0.00137	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CA4—epilepsy syndrome	5.76e-05	0.00137	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CASP3—epilepsy syndrome	5.75e-05	0.00136	CbGpPWpGaD
Risedronate—Nausea—Topiramate—epilepsy syndrome	5.7e-05	0.000127	CcSEcCtD
Risedronate—PTGS2—Disease—STX1B—epilepsy syndrome	5.61e-05	0.00133	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GPX1—epilepsy syndrome	5.56e-05	0.00132	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MMP9—epilepsy syndrome	5.43e-05	0.00129	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—COX3—epilepsy syndrome	5.42e-05	0.00128	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—TNF—epilepsy syndrome	5.29e-05	0.00125	CbGpPWpGaD
Risedronate—PTGS2—Disease—CPSF4—epilepsy syndrome	5.22e-05	0.00124	CbGpPWpGaD
Risedronate—PTGS2—Disease—GBE1—epilepsy syndrome	5.22e-05	0.00124	CbGpPWpGaD
Risedronate—PTGS2—Disease—PPP1R3C—epilepsy syndrome	5.22e-05	0.00124	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	5.17e-05	0.00123	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC6A8—epilepsy syndrome	5.14e-05	0.00122	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—KCNB1—epilepsy syndrome	5.14e-05	0.00122	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CACNA2D2—epilepsy syndrome	5.14e-05	0.00122	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PFKL—epilepsy syndrome	5.14e-05	0.00122	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLCO1A2—epilepsy syndrome	5.14e-05	0.00122	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	5.02e-05	0.00119	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	4.99e-05	0.00118	CbGpPWpGaD
Risedronate—FDPS—Metabolism—AGT—epilepsy syndrome	4.87e-05	0.00116	CbGpPWpGaD
Risedronate—FDPS—Metabolism—APOE—epilepsy syndrome	4.78e-05	0.00113	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ATIC—epilepsy syndrome	4.7e-05	0.00111	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—UPB1—epilepsy syndrome	4.7e-05	0.00111	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NEU1—epilepsy syndrome	4.7e-05	0.00111	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	4.67e-05	0.00111	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HSD17B4—epilepsy syndrome	4.52e-05	0.00107	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	4.44e-05	0.00105	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GBE1—epilepsy syndrome	4.37e-05	0.00104	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPP1R3C—epilepsy syndrome	4.37e-05	0.00104	CbGpPWpGaD
Risedronate—PTGS2—Disease—ST3GAL3—epilepsy syndrome	4.34e-05	0.00103	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	4.27e-05	0.00101	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TNF—epilepsy syndrome	4.18e-05	0.000991	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ASAH1—epilepsy syndrome	4.11e-05	0.000974	CbGpPWpGaD
Risedronate—FDPS—Metabolism—POMC—epilepsy syndrome	4.1e-05	0.000973	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—STXBP1—epilepsy syndrome	3.99e-05	0.000947	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	3.91e-05	0.000927	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NT5E—epilepsy syndrome	3.89e-05	0.000923	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALAD—epilepsy syndrome	3.89e-05	0.000923	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	3.8e-05	0.000901	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALB—epilepsy syndrome	3.74e-05	0.000887	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CACNA1A—epilepsy syndrome	3.71e-05	0.00088	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALDH7A1—epilepsy syndrome	3.71e-05	0.00088	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ST3GAL3—epilepsy syndrome	3.63e-05	0.000862	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ADSL—epilepsy syndrome	3.56e-05	0.000844	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GLUL—epilepsy syndrome	3.49e-05	0.000828	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CACNA1D—epilepsy syndrome	3.43e-05	0.000813	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	3.41e-05	0.000808	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	3.32e-05	0.000787	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PTGS2—epilepsy syndrome	3.27e-05	0.000776	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—TXNRD1—epilepsy syndrome	3.21e-05	0.00076	CbGpPWpGaD
Risedronate—PTGS2—Disease—EIF2AK2—epilepsy syndrome	3.16e-05	0.000749	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AQP1—epilepsy syndrome	3.11e-05	0.000738	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.99e-05	0.000709	CbGpPWpGaD
Risedronate—PTGS2—Disease—PPIA—epilepsy syndrome	2.92e-05	0.000693	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.84e-05	0.000674	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—KCNJ11—epilepsy syndrome	2.81e-05	0.000667	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CHRM3—epilepsy syndrome	2.81e-05	0.000667	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.62e-05	0.000621	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.57e-05	0.000609	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCG2—epilepsy syndrome	2.29e-05	0.000544	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP2C19—epilepsy syndrome	2.24e-05	0.00053	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP11A1—epilepsy syndrome	2.22e-05	0.000527	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.21e-05	0.000523	CbGpPWpGaD
Risedronate—PTGS2—Disease—SLC2A1—epilepsy syndrome	2.17e-05	0.000513	CbGpPWpGaD
Risedronate—PTGS2—Disease—JUNB—epilepsy syndrome	2.15e-05	0.00051	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS1—epilepsy syndrome	2.13e-05	0.000506	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.12e-05	0.000502	CbGpPWpGaD
Risedronate—PTGS2—Disease—HBEGF—epilepsy syndrome	2.04e-05	0.000483	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.01e-05	0.000477	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	2.01e-05	0.000475	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKT3—epilepsy syndrome	2e-05	0.000474	CbGpPWpGaD
Risedronate—PTGS2—Disease—ADAM10—epilepsy syndrome	1.95e-05	0.000463	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	1.91e-05	0.000453	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—BCHE—epilepsy syndrome	1.9e-05	0.000451	CbGpPWpGaD
Risedronate—PTGS2—Disease—CDC42—epilepsy syndrome	1.82e-05	0.000432	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	1.81e-05	0.00043	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PLCB1—epilepsy syndrome	1.79e-05	0.000425	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—TH—epilepsy syndrome	1.79e-05	0.000424	CbGpPWpGaD
Risedronate—PTGS2—Disease—HES1—epilepsy syndrome	1.67e-05	0.000396	CbGpPWpGaD
Risedronate—FDPS—Metabolism—AKT1—epilepsy syndrome	1.64e-05	0.00039	CbGpPWpGaD
Risedronate—PTGS2—Disease—FYN—epilepsy syndrome	1.62e-05	0.000385	CbGpPWpGaD
Risedronate—PTGS2—Disease—H2AFX—epilepsy syndrome	1.62e-05	0.000383	CbGpPWpGaD
Risedronate—PTGS2—Disease—YWHAZ—epilepsy syndrome	1.56e-05	0.00037	CbGpPWpGaD
Risedronate—PTGS2—Disease—CCR5—epilepsy syndrome	1.5e-05	0.000356	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HMOX1—epilepsy syndrome	1.49e-05	0.000354	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CAT—epilepsy syndrome	1.47e-05	0.000349	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCB1—epilepsy syndrome	1.43e-05	0.000339	CbGpPWpGaD
Risedronate—PTGS2—Disease—TSC2—epilepsy syndrome	1.4e-05	0.000331	CbGpPWpGaD
Risedronate—PTGS2—Disease—APOE—epilepsy syndrome	1.37e-05	0.000324	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GPX1—epilepsy syndrome	1.33e-05	0.000316	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6ST—epilepsy syndrome	1.28e-05	0.000304	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS2—epilepsy syndrome	1.27e-05	0.000302	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AGT—epilepsy syndrome	1.17e-05	0.000277	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—APOE—epilepsy syndrome	1.14e-05	0.000271	CbGpPWpGaD
Risedronate—PTGS2—Disease—FGF2—epilepsy syndrome	1.04e-05	0.000246	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—POMC—epilepsy syndrome	9.83e-06	0.000233	CbGpPWpGaD
Risedronate—PTGS2—Disease—MTOR—epilepsy syndrome	9.44e-06	0.000224	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALB—epilepsy syndrome	8.96e-06	0.000212	CbGpPWpGaD
Risedronate—PTGS2—Disease—SRC—epilepsy syndrome	7.57e-06	0.000179	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKT1—epilepsy syndrome	4.7e-06	0.000111	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AKT1—epilepsy syndrome	3.94e-06	9.34e-05	CbGpPWpGaD
